NEW YORK (GenomeWeb News) – Bruker BioSciences announced today that it will acquire its privately held Bruker BioSpin affiliate for $914 million in cash and stock.
 
Bruker BioSpin develops and manufactures life science and analytical research instruments based on its magnetic resonance core technology. The firm is 100 percent-owned by members of the Laukien family, who also own 52 percent of publicly traded Bruker BioSciences.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.